{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:35:19Z","timestamp":1791005719869,"version":"4.1.0"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s12016-021-08919-5","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T10:02:48Z","timestamp":1643450568000},"page":"505-518","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Road Less Traveled: Drug Hypersensitivity to Fluoroquinolones, Vancomycin, Tetracyclines, and Macrolides"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6246-4300","authenticated-orcid":false,"given":"Linda J.","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Y.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla H.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Chen","family":"Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,29]]},"reference":[{"key":"8919_CR1","first-page":"9","volume":"22","author":"I Do\u00f1a","year":"2012","unstructured":"Do\u00f1a I, Blanca-L\u00f3pez N, Torres M, Garc\u00eda-Campos J, Garc\u00eda-N\u00fa\u00f1ez I, G\u00f3mez F et al (2012) Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. J Investig Allergol Clin Immunol 22:9","journal-title":"J Investig Allergol Clin Immunol"},{"key":"8919_CR2","doi-asserted-by":"crossref","unstructured":"Do\u00f1a I, P\u00e9rez-S\u00e1nchez N, Salas M, Barrionuevo E, Ruiz-San Francisco A, de Rojas DH et al (2020) Clinical characterization and diagnostic approaches for patients reporting hypersensitivity reactions to quinolones. J Allergy Clin Immunol Pract\u00a08:2707\u20132714.e2","DOI":"10.1016\/j.jaip.2020.04.051"},{"key":"8919_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature14022","volume":"519","author":"BD McNeil","year":"2015","unstructured":"McNeil BD, Pundir P, Meeker S, Han L, Undem BJ, Kulka M et al (2015) Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions. Nature 519:237\u2013241","journal-title":"Nature"},{"key":"8919_CR4","doi-asserted-by":"crossref","unstructured":"McGee EU, Samuel E, Boronea B, Dillard N, Milby MN, Lewis SJ (2019) Quinolone allergy. Pharm J Pharm Educ Pract [Internet] [cited 25 Oct 2019]7. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6789783\/","DOI":"10.3390\/pharmacy7030097"},{"key":"8919_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg212","volume":"51","author":"MI Andersson","year":"2003","unstructured":"Andersson MI (2003) Development of the quinolones. J Antimicrob Chemother 51:1\u201311","journal-title":"J Antimicrob Chemother"},{"key":"8919_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jaip.2018.06.010","volume":"7","author":"N Dhopeshwarkar","year":"2019","unstructured":"Dhopeshwarkar N, Sheikh A, Doan R, Topaz M, Bates DW, Blumenthal KG et al (2019) Drug-induced anaphylaxis documented in electronic health records. J Allergy Clin Immunol Pract 7:103\u2013111","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8919_CR7","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/pds.3499","volume":"22","author":"SC Jones","year":"2013","unstructured":"Jones SC, Budnitz DS, Sorbello A, Mehta H (2013) US-based emergency department visits for fluoroquinolone-associated hypersensitivity reactions. Pharmacoepidemiol Drug Saf 22:1099\u20131106","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"8919_CR8","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/cea.12099","volume":"43","author":"N Blanca-L\u00f3pez","year":"2013","unstructured":"Blanca-L\u00f3pez N, Ariza A, Do\u00f1a I, Mayorga C, Monta\u00f1ez MI, Garcia-Campos J et al (2013) Hypersensitivity reactions to fluoroquinolones: analysis of the factors involved. Clin Exp Allergy 43:560\u2013567","journal-title":"Clin Exp Allergy"},{"key":"8919_CR9","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.2165\/00002018-200629110-00008","volume":"29","author":"B Sachs","year":"2006","unstructured":"Sachs B, Riegel S, Seebeck J, Beier R, Schichler D, Barger A et al (2006) Fluoroquinolone-associated anaphylaxis in spontaneous adverse drug reaction reports in Germany: differences in reporting rates between individual fluoroquinolones and occurrence after first-ever use. Drug Saf 29:1087\u20131100","journal-title":"Drug Saf"},{"key":"8919_CR10","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1007\/s11096-018-0613-0","volume":"40","author":"GC Wall","year":"2018","unstructured":"Wall GC, Taylor MJ, Smith HL (2018) Prevalence and characteristics of hospital inpatients with reported fluoroquinolone allergy. Int J Clin Pharm 40:890\u2013894","journal-title":"Int J Clin Pharm"},{"key":"8919_CR11","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1111\/j.1365-2222.2009.03338.x","volume":"39","author":"CS Seitz","year":"2009","unstructured":"Seitz CS, Br\u00f6cker EB, Trautmann A (2009) Diagnostic testing in suspected fluoroquinolone hypersensitivity. Clin Exp Allergy 39:1738\u20131745","journal-title":"Clin Exp Allergy"},{"key":"8919_CR12","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.jaip.2020.08.006","volume":"8","author":"AD Broyles","year":"2020","unstructured":"Broyles AD, Banerji A, Barmettler S, Biggs CM, Blumenthal K, Brennan PJ et al (2020) Practical guidance for the evaluation and management of drug hypersensitivity: specific drugs. J Allergy Clin Immunol Pract 8:S16-116","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8919_CR13","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jaip.2018.08.013","volume":"7","author":"AR Wolfson","year":"2019","unstructured":"Wolfson AR, Zhou L, Li Y, Phadke NA, Chow OA, Blumenthal KG (2019) Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome identified in the electronic health record allergy module. J Allergy Clin Immunol Pract 7:633\u2013640","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8919_CR14","doi-asserted-by":"crossref","unstructured":"Scherer K, Bircher AJ (2005) Hypersensitivity reactions to fluoroquinolones. Curr Allergy Asthma Rep 15\u201321","DOI":"10.1007\/s11882-005-0049-1"},{"key":"8919_CR15","doi-asserted-by":"crossref","unstructured":"Blyth DM, Markelz E, Okulicz JF (2012) Cutaneous leukocytoclastic vasculitis associated with levofloxacin therapy. Infect Dis Rep [Internet] [cited 22\u00a0Mar 2021]4. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3892663\/","DOI":"10.4081\/idr.2012.e11"},{"key":"8919_CR16","doi-asserted-by":"crossref","unstructured":"Kuula LSM, Viljemaa KM, Backman JT, Blom M (2019) Fluoroquinolone-related adverse events resulting in health service use and costs: a systematic review. PLoS One [Internet] [cited 22\u00a0Mar 2021]14. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6485715\/","DOI":"10.1371\/journal.pone.0216029"},{"key":"8919_CR17","unstructured":"U.S. Food and Drug Administration (2020) FDA updates warnings for fluoroquinolone antibiotics on risks of mental health and low blood sugar adverse reactions [Internet]. FDA [cited 5 Mar 2021]. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-updates-warnings-fluoroquinolone-antibiotics-risks-mental-healthand-low-blood-sugar-adverse"},{"key":"8919_CR18","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jaci.2016.04.051","volume":"138","author":"H Subramanian","year":"2016","unstructured":"Subramanian H, Gupta K, Ali H (2016) Roles of Mas-related G protein\u2013coupled receptor X2 on mast cell\u2013mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases. J Allergy Clin Immunol 138:700\u2013710","journal-title":"J Allergy Clin Immunol"},{"key":"8919_CR19","doi-asserted-by":"crossref","unstructured":"Porebski G, Kwiecien K, Pawica M, Kwitniewski M (2018) Mas-related G protein-coupled receptor-X2 (MRGPRX2) in drug hypersensitivity reactions. Front Immunol\u00a09","DOI":"10.3389\/fimmu.2018.03027"},{"key":"8919_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jaci.2003.09.035","volume":"113","author":"M Manfredi","year":"2004","unstructured":"Manfredi M, Severino M, Testi S, Macchia D, Ermini G, Pichler WJ et al (2004) Detection of specific IgE to quinolones. J Allergy Clin Immunol 113:155\u2013160","journal-title":"J Allergy Clin Immunol"},{"key":"8919_CR21","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1172\/JCI85538","volume":"126","author":"N Gaudenzio","year":"2016","unstructured":"Gaudenzio N, Sibilano R, Marichal T, Starkl P, Reber LL, Cenac N et al (2016) Different activation signals induce distinct mast cell degranulation strategies. J Clin Invest 126:3981\u20133998","journal-title":"J Clin Invest"},{"key":"8919_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.intimp.2019.02.001","volume":"70","author":"R Liu","year":"2019","unstructured":"Liu R, Hu S, Zhang Y, Che D, Cao J, Wang J et al (2019) Mast cell-mediated hypersensitivity to fluoroquinolone is MRGPRX2 dependent. Int Immunopharmacol 70:417\u2013427","journal-title":"Int Immunopharmacol"},{"key":"8919_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1365-2222.2006.02402.x","volume":"36","author":"DA Schmid","year":"2006","unstructured":"Schmid DA, Depta JPH, Pichler WJ (2006) T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity. Clin Exp Allergy 36:59\u201369","journal-title":"Clin Exp Allergy"},{"key":"8919_CR24","first-page":"6","volume":"17","author":"MV Venturini D\u00edaz","year":"2007","unstructured":"Venturini D\u00edaz MV, Labairu TL, Mahave IG (2007) In vivo diagnostic tests in adverse reactions to quinolones. J Investig Allergol Clin Immunol 17:6","journal-title":"J Investig Allergol Clin Immunol"},{"key":"8919_CR25","doi-asserted-by":"crossref","unstructured":"Krantz MS, Stone CA, Yu R, Adams SN, Phillips EJ (2020) Criteria for intradermal skin testing and oral challenge in patients labeled as fluoroquinolone allergic. J Allergy Clin Immunol Pract S221321982030965X","DOI":"10.1016\/j.jaci.2019.12.066"},{"key":"8919_CR26","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.jaip.2014.12.012","volume":"3","author":"AP Uyttebroek","year":"2015","unstructured":"Uyttebroek AP, Sabato V, Bridts CH, De Clerck LS, Ebo DG (2015) Moxifloxacin hypersensitivity: uselessness of skin testing. J Allergy Clin Immunol Pract 3:443\u2013445","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8919_CR27","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0091-6749(03)01783-4","volume":"112","author":"R Empedrad","year":"2003","unstructured":"Empedrad R, Darter AL, Earl HS, Gruchalla RS (2003) Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics. J Allergy Clin Immunol 112:629\u2013630","journal-title":"J Allergy Clin Immunol"},{"key":"8919_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1398-9995.2010.02460.x","volume":"66","author":"A Aranda","year":"2011","unstructured":"Aranda A, Mayorga C, Ariza A, Do\u00f1a I, Rosado A, Blanca-Lopez N et al (2011) In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones. Allergy 66:247\u2013254","journal-title":"Allergy"},{"key":"8919_CR29","doi-asserted-by":"crossref","unstructured":"Loli\u2010Ausejo D, V\u00edlchez\u2010S\u00e1nchez F, Caba\u00f1as R, Fiandor A, Lluch\u2010Bernal M, Gonz\u00e1lez\u2010Mu\u00f1oz M et al (2021) Basophil activation test in the diagnosis of hypersensitivity reactions to quinolones in a real-life setting. Clin Exp Allergy [Internet] [cited 4 Mar 2021]n\/a. Available from: http:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1111\/cea.13817","DOI":"10.1111\/cea.13817"},{"key":"8919_CR30","first-page":"607","volume":"20","author":"T Lobera","year":"2010","unstructured":"Lobera T, Aud\u00edcana MT, Alarc\u00f3n E, Longo N, Navarro B, Mu\u00f1oz D (2010) Allergy to quinolones: low cross-reactivity to levofloxacin. J Investig Allergol Clin Immunol 20:607\u2013611","journal-title":"J Investig Allergol Clin Immunol"},{"key":"8919_CR31","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1345\/aph.1M579","volume":"44","author":"B Chang","year":"2010","unstructured":"Chang B, Knowles SR, Weber E (2010) Immediate hypersensitivity to moxifloxacin with tolerance to ciprofloxacin: report of three cases and review of the literature. Ann Pharmacother 44:740\u2013745","journal-title":"Ann Pharmacother"},{"key":"8919_CR32","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/S0091-6749(95)70240-7","volume":"96","author":"RR Lantner","year":"1995","unstructured":"Lantner RR (1995) Ciprofloxacin desensitization in a patient with cystic fibrosis. J Allergy Clin Immunol 96:1001\u20131002","journal-title":"J Allergy Clin Immunol"},{"key":"8919_CR33","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1086\/491709","volume":"42","author":"DP Levine","year":"2006","unstructured":"Levine DP (2006) Vancomycin: a history. Clin Infect Dis 42:S5-12","journal-title":"Clin Infect Dis"},{"key":"8919_CR34","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1001\/jamainternmed.2016.5651","volume":"176","author":"J Baggs","year":"2016","unstructured":"Baggs J, Fridkin SK, Pollack LA, Srinivasan A, Jernigan JA (2016) Estimating national trends in inpatient antibiotic use among US hospitals from 2006 to 2012. JAMA Intern Med 176:1639","journal-title":"JAMA Intern Med"},{"key":"8919_CR35","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ et al (2011) Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant staphylococcus aureus infections in adults and children. Clin Infect Dis 52:e18-55","journal-title":"Clin Infect Dis"},{"key":"8919_CR36","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/cix1085","volume":"66","author":"LC McDonald","year":"2018","unstructured":"McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE et al (2018) Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 66:e1-48","journal-title":"Clin Infect Dis"},{"key":"8919_CR37","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jaip.2020.09.027","volume":"9","author":"S Alvarez-Arango","year":"2021","unstructured":"Alvarez-Arango S, Yerneni S, Tang O, Zhou L, Mancini CM, Blackley SV et al (2021) Vancomycin hypersensitivity reactions documented in electronic health records. J Allergy Clin Immunol Pract 9:906\u2013912","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8919_CR38","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jaip.2016.12.022","volume":"5","author":"SK Lin","year":"2017","unstructured":"Lin SK, Mulieri KM, Ishmael FT (2017) Characterization of vancomycin reactions and linezolid utilization in the pediatric population. J Allergy Clin Immunol Pract 5:750\u2013756","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8919_CR39","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/infdis\/157.3.502","volume":"157","author":"RE Polk","year":"1988","unstructured":"Polk RE, Healy DP, Schwartz LB, Rock DT, Garson ML, Roller K (1988) Vancomycin and the red-man syndrome: pharmacodynamics of histamine release. J Infect Dis 157:502\u2013507","journal-title":"J Infect Dis"},{"key":"8919_CR40","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1128\/AAC.37.10.2139","volume":"37","author":"RE Polk","year":"1993","unstructured":"Polk RE, Israel D, Wang J, Venitz J, Miller J, Stotka J (1993) Vancomycin skin tests and prediction of red man syndrome in healthy volunteers. Antimicrob Agents Chemother 37:2139\u20132143","journal-title":"Antimicrob Agents Chemother"},{"key":"8919_CR41","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1093\/infdis\/168.3.773","volume":"168","author":"TL O\u2019Sullivan","year":"1993","unstructured":"O\u2019Sullivan TL, Ruffing MJ, Lamp KC, Warbasse LH, Rybak MJ (1993) Prospective evaluation of red man syndrome in patients receiving vancomycin. J Infect Dis 168:773\u2013776","journal-title":"J Infect Dis"},{"key":"8919_CR42","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/infdis\/164.6.1180","volume":"164","author":"MR Wallace","year":"1991","unstructured":"Wallace MR, Mascola JR, Oldfield EC (1991) Red man syndrome: incidence, etiology, and prophylaxis. J Infect Dis 164:1180\u20131185","journal-title":"J Infect Dis"},{"key":"8919_CR43","doi-asserted-by":"publisher","first-page":"581","DOI":"10.7326\/0003-4819-91-4-581","volume":"91","author":"P Newfield","year":"1979","unstructured":"Newfield P (1979) Hazards of rapid administration of vancomycin. Ann Intern Med 91:581","journal-title":"Ann Intern Med"},{"key":"8919_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13256-020-02639-8","volume":"15","author":"S Khakurel","year":"2021","unstructured":"Khakurel S, Rawal S (2021) Vancomycin induced cardiac arrest: a case report. J Med Case Reports 15:77","journal-title":"J Med Case Reports"},{"key":"8919_CR45","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1097\/ACI.0000000000000665","volume":"20","author":"JF De Luca","year":"2020","unstructured":"De Luca JF, Holmes NE, Trubiano JA (2020) Adverse reactions to vancomycin and cross-reactivity with other antibiotics. Curr Opin Allergy Clin Immunol 20:352\u2013361","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"8919_CR46","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.anai.2016.03.030","volume":"116","author":"JS Minhas","year":"2016","unstructured":"Minhas JS, Wickner PG, Long AA, Banerji A, Blumenthal KG (2016) Immune-mediated reactions to vancomycin: A systematic case review and analysis. Ann Allergy Asthma Immunol 116:544\u2013553","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8919_CR47","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.jaip.2015.06.017","volume":"3","author":"IM Otani","year":"2015","unstructured":"Otani IM, Kuhlen JL, Blumenthal KG, Guyer A, Banerji A (2015) A role for vancomycin epicutaneous skin testing in the evaluation of perioperative anaphylaxis. J Allergy Clin Immunol Pract 3:984\u2013985","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8919_CR48","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s15010-012-0328-4","volume":"41","author":"D Boss\u00e9","year":"2013","unstructured":"Boss\u00e9 D, Lemire C, Ruel J, Cantin AM, M\u00e9nard F, Valiquette L (2013) Severe anaphylaxis caused by orally administered vancomycin to a patient with Clostridium difficile infection. Infection 41:579\u2013582","journal-title":"Infection"},{"key":"8919_CR49","first-page":"30","volume":"46","author":"R Kupstaite","year":"2010","unstructured":"Kupstaite R, Baranauskaite A, Pileckyte M, Sveikata A, Kadusevicius E, Muckiene G (2010) Severe vancomycin-induced anaphylactic reaction. Med Kaunas Lith 46:30\u201333","journal-title":"Med Kaunas Lith"},{"key":"8919_CR50","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2169\/internalmedicine.45.1388","volume":"45","author":"T Kitazawa","year":"2006","unstructured":"Kitazawa T, Ota Y, Kada N, Morisawa Y, Yoshida A, Koike K et al (2006) Successful vancomycin desensitization with a combination of rapid and slow infusion methods. Intern Med 45:317\u2013321","journal-title":"Intern Med"},{"key":"8919_CR51","first-page":"319","volume":"7","author":"H Hassaballa","year":"2000","unstructured":"Hassaballa H, Mallick N, Orlowski J (2000) Vancomycin anaphylaxis in a patient with vancomycin-induced red man syndrome. J Ther 7:319\u2013320","journal-title":"J Ther"},{"key":"8919_CR52","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S1081-1206(10)62416-7","volume":"84","author":"N Chopra","year":"2000","unstructured":"Chopra N, Oppenheimer J, Derimanov GS, Fine PL (2000) Vancomycin anaphylaxis and successful desensitization in a patient with end stage renal disease on hemodialysis by maintaining steady antibiotic levels. Ann Allergy Asthma Immunol 84:633\u2013635","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8919_CR53","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S0091-6749(97)70287-2","volume":"100","author":"AT Villavicencio","year":"1997","unstructured":"Villavicencio AT, Hey LA, Patel D, Bressler P (1997) Acute cardiac and pulmonary arrest after infusion of vancomycin with subsequent desensitization. J Allergy Clin Immunol 100:853\u2013854","journal-title":"J Allergy Clin Immunol"},{"key":"8919_CR54","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.krcp.2014.09.005","volume":"34","author":"M-J Hwang","year":"2015","unstructured":"Hwang M-J, Do J-Y, Choi E-W, Seo J-H, Nam Y-J, Yoon K-W et al (2015) Immunoglobulin E-mediated hypersensitivity reaction after intraperitoneal administration of vancomycin. Kidney Res Clin Pract 34:57\u201359","journal-title":"Kidney Res Clin Pract"},{"key":"8919_CR55","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0140-6736(18)32218-9","volume":"393","author":"KG Blumenthal","year":"2019","unstructured":"Blumenthal KG, Peter JG, Trubiano JA, Phillips EJ (2019) Antibiotic allergy. The Lancet 393:183\u2013198","journal-title":"The Lancet"},{"key":"8919_CR56","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.jaad.2017.05.041","volume":"77","author":"BD Lam","year":"2017","unstructured":"Lam BD, Miller MM, Sutton AV, Peng D, Crew AB (2017) Vancomycin and DRESS: a retrospective chart review of 32 cases in Los Angeles. California J Am Acad Dermatol 77:973\u2013975","journal-title":"California J Am Acad Dermatol"},{"key":"8919_CR57","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jaci.2015.04.005","volume":"136","author":"KG Blumenthal","year":"2015","unstructured":"Blumenthal KG, Youngster I, Rabideau DJ, Parker RA, Manning KS, Walensky RP et al (2015) Peripheral blood eosinophilia and hypersensitivity reactions among patients receiving outpatient parenteral antibiotics. J Allergy Clin Immunol 136:1288-1294.e1","journal-title":"J Allergy Clin Immunol"},{"key":"8919_CR58","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jaci.2020.04.056","volume":"147","author":"N Nakkam","year":"2021","unstructured":"Nakkam N, Gibson A, Mouhtouris E, Konvinse KC, Holmes NE, Chua KY et al (2021) Cross-reactivity between vancomycin, teicoplanin, and telavancin in patients with HLA-A\u221732:01\u2013positive vancomycin-induced DRESS sharing an HLA class II haplotype. J Allergy Clin Immunol 147:403\u2013405","journal-title":"J Allergy Clin Immunol"},{"key":"8919_CR59","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2500\/aap.2012.33.3498","volume":"33","author":"K Blumenthal","year":"2012","unstructured":"Blumenthal K, Patil S, Long A (2012) The importance of vancomycin in drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. Allergy Asthma Proc Off J Reg State Allergy Soc 33:165\u2013171","journal-title":"Allergy Asthma Proc Off J Reg State Allergy Soc"},{"key":"8919_CR60","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jaad.2019.02.002","volume":"81","author":"LM Madigan","year":"2019","unstructured":"Madigan LM, Fox LP (2019) Vancomycin-associated drug-induced hypersensitivity syndrome. J Am Acad Dermatol 81:123\u2013128","journal-title":"J Am Acad Dermatol"},{"key":"8919_CR61","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/j.1365-2230.2004.01649.x","volume":"29","author":"MA Waldman","year":"2004","unstructured":"Waldman MA, Black DR, Callen JP (2004) Vancomycin-induced linear IgA bullous disease presenting as toxic epidermal necrolysis. Clin Exp Dermatol 29:633\u2013636","journal-title":"Clin Exp Dermatol"},{"key":"8919_CR62","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/bcp.13827","volume":"85","author":"B Garel","year":"2019","unstructured":"Garel B, Ingen-Housz-Oro S, Afriat D, Prost-Squarcioni C, T\u00e9tart F, Bensaid B et al (2019) Drug-induced linear immunoglobulin A bullous dermatosis: a French retrospective pharmacovigilance study of 69 cases. Br J Clin Pharmacol 85:570\u2013579","journal-title":"Br J Clin Pharmacol"},{"key":"8919_CR63","doi-asserted-by":"publisher","first-page":"508","DOI":"10.2340\/00015555-3154","volume":"99","author":"J Lammer","year":"2019","unstructured":"Lammer J, Hein R, Roenneberg S, Biedermann T, Volz T (2019) Drug-induced Linear IgA bullous dermatosis: a case report and review of the literature. Acta Derm Venereol 99:508\u2013515","journal-title":"Acta Derm Venereol"},{"key":"8919_CR64","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13223-018-0293-2","volume":"14","author":"J Barron","year":"2018","unstructured":"Barron J, Lattes A, Marcus E-L (2018) Rash induced by enteral vancomycin therapy in an older patient in a long-term care ventilator unit: case report and review of the literature. Allergy Asthma Clin Immunol Off J Can Soc Allergy Clin Immunol 14:73","journal-title":"Allergy Asthma Clin Immunol Off J Can Soc Allergy Clin Immunol"},{"key":"8919_CR65","doi-asserted-by":"publisher","first-page":"11628","DOI":"10.1038\/s41598-018-29965-8","volume":"8","author":"A Navin\u00e9s-Ferrer","year":"2018","unstructured":"Navin\u00e9s-Ferrer A, Serrano-Candelas E, Lafuente A, Mu\u00f1oz-Cano R, Mart\u00edn M, Gastaminza G (2018) MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia. Sci Rep 8:11628","journal-title":"Sci Rep"},{"key":"8919_CR66","doi-asserted-by":"crossref","unstructured":"Azimi E, Reddy VB, Shade K-TC, Anthony RM, Talbot S, Pereira PJS et al (2016) Dual action of neurokinin-1 antagonists on Mas-related GPCRs [Internet]. American Society for Clinical Investigation [cited 7 Mar 2021]. Available from: http:\/\/insight.jci.org\/articles\/view\/89362\/pdf","DOI":"10.1172\/jci.insight.89362"},{"key":"8919_CR67","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jaci.2019.01.045","volume":"144","author":"KC Konvinse","year":"2019","unstructured":"Konvinse KC, Trubiano JA, Pavlos R, James I, Shaffer CM, Bejan CA et al (2019) HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms. J Allergy Clin Immunol 144:183\u2013192","journal-title":"J Allergy Clin Immunol"},{"key":"8919_CR68","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/00000542-199809000-00010","volume":"89","author":"CL Renz","year":"1998","unstructured":"Renz CL, Laroche D, Thurn JD, Finn HA, Lynch JP, Thisted R et al (1998) Tryptase levels are not increased during vancomycin-induced anaphylactoid reactions. Anesthesiology 89:620\u2013625","journal-title":"Anesthesiology"},{"key":"8919_CR69","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1345\/aph.1A002","volume":"35","author":"LD Wazny","year":"2001","unstructured":"Wazny LD, Daghigh B (2001) Desensitization protocols for vancomycin hypersensitivity. Ann Pharmacother 35:1458\u20131464","journal-title":"Ann Pharmacother"},{"key":"8919_CR70","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s10875-019-00707-3","volume":"39","author":"S Noguchi","year":"2019","unstructured":"Noguchi S, Takekawa D, Saito J, Hashiba E, Hirota K (2019) Serum tryptase cannot differentiate vancomycin-induced anaphylaxis from red man syndrome. J Clin Immunol 39:855\u2013856","journal-title":"J Clin Immunol"},{"key":"8919_CR71","doi-asserted-by":"crossref","unstructured":"Alvarez\u2010Arango S, Oliver E, Tang O, Saha T, Keet CA, Adkinson NF et al (2021) Vancomycin immediate skin responses in vancomycin-na\u00efve subjects. Clin Exp Allergy [Internet] [cited 7\u00a0Mar 2021]n\/a. Available from: http:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.1111\/cea.13850","DOI":"10.1111\/cea.13850"},{"key":"8919_CR72","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jmoldx.2019.04.006","volume":"21","author":"FX Rwandamuriye","year":"2019","unstructured":"Rwandamuriye FX, Chopra A, Konvinse KC, Choo L, Trubiano JA, Shaffer CM et al (2019) A rapid allele-specific assay for HLA-A*32:01 to identify patients at risk for vancomycin-induced drug reaction with eosinophilia and systemic symptoms. J Mol Diagn 21:782\u2013789","journal-title":"J Mol Diagn"},{"key":"8919_CR73","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.jaip.2020.10.040","volume":"9","author":"OS Kayode","year":"2021","unstructured":"Kayode OS, Rutkowski K (2021) Vancomycin hypersensitivity: it is not always what it seems. J Allergy Clin Immunol Pract 9:913\u2013915","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8919_CR74","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1128\/AAC.34.4.550","volume":"34","author":"DP Healy","year":"1990","unstructured":"Healy DP, Sahai JV, Fuller SH, Polk RE (1990) Vancomycin-induced histamine release and red man syndrome: comparison of 1- and 2-hour infusions. Antimicrob Agents Chemother 34:550\u2013554","journal-title":"Antimicrob Agents Chemother"},{"key":"8919_CR75","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/infdis\/160.5.876","volume":"160","author":"J Sahai","year":"1989","unstructured":"Sahai J, Healy DP, Garris R, Berry A, Polk RE (1989) Influence of antihistamine pretreatment on vancomycin-induced red-man syndrome. J Infect Dis 160:876\u2013881","journal-title":"J Infect Dis"},{"key":"8919_CR76","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1097\/00003246-199909000-00006","volume":"27","author":"CL Renz","year":"1999","unstructured":"Renz CL, Thurn JD, Finn HA, Lynch JP, Moss J (1999) Antihistamine prophylaxis permits rapid vancomycin infusion. Crit Care Med 27:1732\u20131737","journal-title":"Crit Care Med"},{"key":"8919_CR77","doi-asserted-by":"crossref","unstructured":"Wong JT, Ripple RE, MacLean JA, Marks DR, Bloch KJ (1994)\u00a0Vancomycin hypersensitivity: synergism with narcotics and desensitization by a rapid continuous intravenous protocol. J Allergy Clin Immunol 94:189\u201394","DOI":"10.1053\/ai.1994.v94.a55251"},{"key":"8919_CR78","doi-asserted-by":"publisher","first-page":"714","DOI":"10.3904\/kjim.2018.404","volume":"35","author":"B-K Kim","year":"2020","unstructured":"Kim B-K, Kim J-H, Sohn K-H, Kim J-Y, Chang Y-S, Kim S-H (2020) Incidence of teicoplanin adverse drug reactions among patients with vancomycin-associated adverse drug reactions and its risk factors. Korean J Intern Med 35:714\u2013722","journal-title":"Korean J Intern Med"},{"key":"8919_CR79","doi-asserted-by":"crossref","unstructured":"Azimi E, Reddy VB, Lerner EA (2017) MRGPRX2, atopic dermatitis, and red man syndrome. Itch Phila Pa 2:e5","DOI":"10.1097\/itx.0000000000000005"},{"key":"8919_CR80","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1749-6632.2011.06354.x","volume":"1241","author":"ML Nelson","year":"2011","unstructured":"Nelson ML, Levy SB (2011) The history of the tetracyclines. Ann N Y Acad Sci 1241:17\u201332","journal-title":"Ann N Y Acad Sci"},{"key":"8919_CR81","doi-asserted-by":"crossref","unstructured":"Hamilton LA, Guarascio AJ (2019) Tetracycline allergy. Pharm J Pharm Educ Pract [Internet] [cited 19\u00a0Oct 2020]7. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6789857\/","DOI":"10.3390\/pharmacy7030104"},{"key":"8919_CR82","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.amjmed.2013.07.006","volume":"126","author":"JG Verbalis","year":"2013","unstructured":"Verbalis JG, Goldsmith SR, Greenberg A, Korzelius C, Schrier RW, Sterns RH et al (2013) Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med 126:S1-42","journal-title":"Am J Med"},{"key":"8919_CR83","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1056\/NEJMoa1800170","volume":"380","author":"W O\u2019Riordan","year":"2019","unstructured":"O\u2019Riordan W, Green S, Overcash JS, Puljiz I, Metallidis S, Gardovskis J et al (2019) Omadacycline for acute bacterial skin and skin-structure infections. N Engl J Med 380:528\u2013538","journal-title":"N Engl J Med"},{"key":"8919_CR84","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1056\/NEJMoa1800201","volume":"380","author":"R Stets","year":"2019","unstructured":"Stets R, Popescu M, Gonong JR, Mitha I, Nseir W, Madej A et al (2019) Omadacycline for community-acquired bacterial pneumonia. N Engl J Med 380:517\u2013527","journal-title":"N Engl J Med"},{"key":"8919_CR85","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s40265-019-01067-3","volume":"79","author":"LJ Scott","year":"2019","unstructured":"Scott LJ (2019) Eravacycline: a review in complicated intra-abdominal infections. Drugs 79:315\u2013324","journal-title":"Drugs"},{"key":"8919_CR86","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13223-020-0402-x","volume":"16","author":"A Jourdan","year":"2020","unstructured":"Jourdan A, Sangha B, Kim E, Nawaz S, Malik V, Vij R et al (2020) Antibiotic hypersensitivity and adverse reactions: management and implications in clinical practice. Allergy Asthma Clin Immunol 16:6","journal-title":"Allergy Asthma Clin Immunol"},{"key":"8919_CR87","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.clinthera.2005.09.005","volume":"27","author":"K Smith","year":"2005","unstructured":"Smith K, Leyden JJ (2005) Safety of doxycycline and minocycline: a systematic review. Clin Ther 27:1329\u20131342","journal-title":"Clin Ther"},{"key":"8919_CR88","doi-asserted-by":"crossref","unstructured":"Lebrun-Vignes B, Kreft-Jais C, Castot A, Chosidow O (2012) French Network of Regional Centers of Pharmacovigilance. Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature. Br J Dermatol\u00a0166:1333\u201341","DOI":"10.1111\/j.1365-2133.2012.10845.x"},{"key":"8919_CR89","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1001\/archderm.1997.03890460044005","volume":"133","author":"LE Shapiro","year":"1997","unstructured":"Shapiro LE (1997) Comparative safety of tetracycline, minocycline, and doxycycline. Arch Dermatol 133:1224","journal-title":"Arch Dermatol"},{"key":"8919_CR90","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3346\/jkms.2010.25.8.1231","volume":"25","author":"JW Jang","year":"2010","unstructured":"Jang JW, Bae Y-J, Kim YG, Jin Y-J, Park KS, Cho YS et al (2010) A case of anaphylaxis to oral minocycline. J Korean Med Sci 25:1231\u20131233","journal-title":"J Korean Med Sci"},{"key":"8919_CR91","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2340\/0001555576164164","volume":"76","author":"M Okano","year":"1996","unstructured":"Okano M, Imai S (1996) Anaphylactoid symptoms due to oral minocycline. Acta Derm Venereol 76:164","journal-title":"Acta Derm Venereol"},{"key":"8919_CR92","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1346-8138.2010.01021.x","volume":"38","author":"A Ogita","year":"2011","unstructured":"Ogita A, Takada K, Kawana S (2011) Case of anaphylaxis due to tetracycline hydrochloride. J Dermatol 38:597\u2013599","journal-title":"J Dermatol"},{"key":"8919_CR93","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1001\/jama.1965.03080240067023","volume":"192","author":"MJ Fellner","year":"1965","unstructured":"Fellner MJ (1965) Anaphylactic reaction to tetracycline in a penicillin-allergic patient: immunologic studies. JAMA 192:997","journal-title":"JAMA"},{"key":"8919_CR94","first-page":"481","volume":"18","author":"JC Raeder","year":"1984","unstructured":"Raeder JC (1984) Anaphylactoid reaction caused by intravenous doxycycline during general anesthesia and \u03b2-blockade treatment. Drug Intell Clin Pharm 18:481\u2013482","journal-title":"Drug Intell Clin Pharm"},{"key":"8919_CR95","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.anai.2013.05.005","volume":"111","author":"SL Fernando","year":"2013","unstructured":"Fernando SL, Hudson BJ (2013) Rapid desensitization to doxycycline. Ann Allergy Asthma Immunol 111:73\u201374","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8919_CR96","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1046\/j.1365-4362.1998.00451.x","volume":"37","author":"A Mahboob","year":"1998","unstructured":"Mahboob A, Haroon TS (1998) Drugs causing fixed eruptions: a study of 450 cases. Int J Dermatol 37:833\u2013838","journal-title":"Int J Dermatol"},{"key":"8919_CR97","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","volume":"148","author":"N Chalasani","year":"2015","unstructured":"Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J et al (2015) Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology 148:1340-1352.e7","journal-title":"Gastroenterology"},{"key":"8919_CR98","doi-asserted-by":"publisher","first-page":"e745","DOI":"10.1097\/MJT.0000000000000904","volume":"26","author":"M Kulkarni","year":"2019","unstructured":"Kulkarni M, Saxena R, Diaczok B, Nassif H (2019) Tetracycline re-exposure-induced toxic epidermal necrolysis. Am J Ther 26:e745\u2013e747","journal-title":"Am J Ther"},{"key":"8919_CR99","doi-asserted-by":"crossref","unstructured":"Correia O, Delgado L, Polonia J (1999)\u00a0Genital fixed drug eruption: cross-reactivity between doxycycline and minocycline. Clin Exp Dermatol 24:137\u2013137","DOI":"10.1046\/j.1365-2230.1999.00436.x"},{"key":"8919_CR100","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1001\/archderm.1996.03890330150036","volume":"132","author":"SN Tham","year":"1996","unstructured":"Tham SN (1996) Cross-reactivity in fixed drug eruptions to tetracyclines. Arch Dermatol 132:1134","journal-title":"Arch Dermatol"},{"key":"8919_CR101","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/S0190-9622(84)80480-6","volume":"11","author":"H Bargman","year":"1984","unstructured":"Bargman H (1984) Lack of cross-sensitivity between tetracycline, doxycycline, and minocycline with regard to fixed drug sensitivity to tetracycline. J Am Acad Dermatol 11:900\u2013901","journal-title":"J Am Acad Dermatol"},{"key":"8919_CR102","doi-asserted-by":"crossref","unstructured":"Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume J-C et al (2009) Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. Arch Dermatol [Internet]\u00a0[cited 20\u00a0Mar 2021]145. Available from: http:\/\/archderm.jamanetwork.com\/article.aspx?doi=10.1001\/archderm.145.1.67","DOI":"10.1001\/archderm.145.1.67"},{"key":"8919_CR103","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11926-017-0626-z","volume":"19","author":"MH Adwan","year":"2017","unstructured":"Adwan MH (2017) Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome and the rheumatologist. Curr Rheumatol Rep 19:3","journal-title":"Curr Rheumatol Rep"},{"key":"8919_CR104","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000112926","volume":"216","author":"E Maubec","year":"2008","unstructured":"Maubec E, Wolkenstein P, Loriot M-A, Wechsler J, Mulot C, Beaune P et al (2008) Minocycline-Induced DRESS: evidence for accumulation of the culprit drug. Dermatology 216:200\u2013204","journal-title":"Dermatology"},{"key":"8919_CR105","first-page":"159","volume":"6","author":"MS Nisar","year":"2013","unstructured":"Nisar MS, Iyer K, Brodell RT, Lloyd JR, Shin TM, Ahmad A (2013) Minocycline-induced hyperpigmentation: comparison of 3 Q-switched lasers to reverse its effects. Clin Cosmet Investig Dermatol 6:159\u2013162","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"8919_CR106","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.1016\/j.jaad.2012.07.005","volume":"67","author":"C Kalai","year":"2012","unstructured":"Kalai C, Brand R, Yu L (2012) Minocycline-induced Sweet syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 67:e289\u2013e291","journal-title":"J Am Acad Dermatol"},{"key":"8919_CR107","doi-asserted-by":"publisher","first-page":"268","DOI":"10.18176\/jiaci.0164","volume":"27","author":"W Gu","year":"2017","unstructured":"Gu W, Shi D, Mi N, Pang X, Liu W (2017) Physician, beware! Drug fever without skin rashes can be caused by minocycline. J Investig Allergol Clin Immunol 27:268\u2013269","journal-title":"J Investig Allergol Clin Immunol"},{"key":"8919_CR108","doi-asserted-by":"crossref","unstructured":"Lebrun-Vignes B, Kreft-Jais C, Castot A, Chosidow O (2012) the French Network of Regional Centers of Pharmacovigilance. Comparative analysis of adverse drug reactions to tetracyclines: results of a French national survey and review of the literature: comparative analysis of adverse drug reactions to tetracyclines. Br J Dermatol 166:1333\u201341","DOI":"10.1111\/j.1365-2133.2012.10845.x"},{"key":"8919_CR109","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1001\/archinte.1994.00420140105013","volume":"154","author":"O Sitbon","year":"1994","unstructured":"Sitbon O (1994) Minocycline pneumonitis and eosinophilia: a report on eight patients. Arch Intern Med 154:1633","journal-title":"Arch Intern Med"},{"key":"8919_CR110","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1378\/chest.123.6.2146","volume":"123","author":"M Oddo","year":"2003","unstructured":"Oddo M, Liaudet L, Lepori M, Broccard AF, Schaller M-D (2003) Relapsing acute respiratory failure induced by minocyclinea. Chest 123:2146\u20132148","journal-title":"Chest"},{"key":"8919_CR111","doi-asserted-by":"crossref","unstructured":"Shao Q-Q, Qin L, Ruan G-R, Chen R-X, Luan Z-J, Ma X-J (2015) Tigecycline-induced drug fever and leukemoid reaction: a case report. Medicine (Baltimore) 94:e1869","DOI":"10.1097\/MD.0000000000001869"},{"key":"8919_CR112","doi-asserted-by":"crossref","first-page":"030006052092241","DOI":"10.1177\/0300060520922416","volume":"48","author":"J Yang","year":"2020","unstructured":"Yang J, Wu F, Luo D, Li M, Gou X, Xi J et al (2020) Toxic epidermal necrolysis syndrome induced by tigecycline: a case report. J Int Med Res 48:0300060520922416","journal-title":"J Int Med Res"},{"key":"8919_CR113","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.anai.2020.02.007","volume":"124","author":"MC Maciag","year":"2020","unstructured":"Maciag MC, Ward SL, O\u2019Connell AE, Broyles AD (2020) Hypersensitivity to tetracyclines: skin testing, graded challenge, and desensitization regimens. Ann Allergy Asthma Immunol 124:589\u2013593","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8919_CR114","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jaip.2013.08.002","volume":"2","author":"JL Stollings","year":"2014","unstructured":"Stollings JL, Chadha SN, Paul AM, Shaver CM, Hagaman D (2014) Doxycycline desensitization for a suspected case of ehrlichiosis. J Allergy Clin Immunol Pract 2:103\u2013104","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8919_CR115","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.idcr.2018.01.006","volume":"11","author":"AL Caplunik-Pratsch","year":"2018","unstructured":"Caplunik-Pratsch AL, Potasman I, Kessel A, Paz A (2018) Doxycycline desensitization in chronic Q fever\u2014a critical tool for the clinician. IDCases 11:70\u201372","journal-title":"IDCases"},{"key":"8919_CR116","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bcp.2016.10.001","volume":"133","author":"R Aminov","year":"2017","unstructured":"Aminov R (2017) History of antimicrobial drug discovery: major classes and health impact. Biochem Pharmacol 133:4\u201319","journal-title":"Biochem Pharmacol"},{"key":"8919_CR117","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.idc.2009.06.013","volume":"23","author":"JM Zuckerman","year":"2009","unstructured":"Zuckerman JM, Qamar F, Bono BR (2009) Macrolides, ketolides, and glycylcyclines: azithromycin, clarithromycin, telithromycin, tigecycline. Infect Dis Clin North Am 23:997\u20131026","journal-title":"Infect Dis Clin North Am"},{"key":"8919_CR118","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.2174\/138161208786369812","volume":"14","author":"L Ara\u00fajo","year":"2008","unstructured":"Ara\u00fajo L, Demoly P (2008) Macrolides allergy. Curr Pharm Des 14:2840\u20132862","journal-title":"Curr Pharm Des"},{"key":"8919_CR119","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/j.1398-9995.2004.00638.x","volume":"59","author":"S Benahmed","year":"2004","unstructured":"Benahmed S, Scaramuzza C, Messaad D, Sahla H, Demoly P (2004) The accuracy of the diagnosis of suspected macrolide antibiotic hypersensitivity: results of a single-blinded trial. Allergy 59:1130\u20131133","journal-title":"Allergy"},{"key":"8919_CR120","doi-asserted-by":"crossref","unstructured":"Lammintausta K, Kortekangas-Savolainen O (2005) Oral challenge in patients with suspected cutaneous adverse drug reactions: findings in 784 patients during a 25-year-period. Acta Derm Venereol 6","DOI":"10.1080\/00015550510042859"},{"key":"8919_CR121","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/039463201402700116","volume":"27","author":"F Mori","year":"2014","unstructured":"Mori F, Pecorari L, Pantano S, Rossi ME, Pucci N, De Martino M et al (2014) Azithromycin anaphylaxis in children. Int J Immunopathol Pharmacol 27:121\u2013126","journal-title":"Int J Immunopathol Pharmacol"},{"key":"8919_CR122","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.aller.2010.06.008","volume":"39","author":"CS Seitz","year":"2011","unstructured":"Seitz CS, Br\u00f6cker E-B, Trautmann A (2011) Suspicion of macrolide allergy after treatment of infectious diseases including Helicobacter pylori: Results of allergological testing. Allergol Immunopathol (Madr) 39:193\u2013199","journal-title":"Allergol Immunopathol (Madr)"},{"key":"8919_CR123","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/j.1398-9995.2009.01990.x","volume":"64","author":"M Ben-Shoshan","year":"2009","unstructured":"Ben-Shoshan M, Moore A, Primeau MN (2009) Anaphylactic reaction to clarithromycin in a child. Allergy 64:962\u2013963","journal-title":"Allergy"},{"key":"8919_CR124","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/S1081-1206(10)63349-2","volume":"77","author":"G Jorro","year":"1996","unstructured":"Jorro G, Morales C, Bras\u00f3 JV, Pel\u00e1ez A (1996) Anaphylaxis to erythromycin. Ann Allergy Asthma Immunol 77:456\u2013458","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8919_CR125","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jaip.2017.06.036","volume":"6","author":"D \u00dcnal","year":"2018","unstructured":"\u00dcnal D, Demir S, Gelincik A, Olga\u00e7 M, Co\u015fkun R, \u00c7olako\u011flu B et al (2018) Diagnostic value of oral challenge testing in the diagnosis of macrolide hypersensitivity. J Allergy Clin Immunol Pract 6:521\u2013527","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8919_CR126","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2500\/aap.2009.30.3199","volume":"30","author":"M Greenhawt","year":"2009","unstructured":"Greenhawt M, McMorris M, Baldwin J (2009) Carmine hypersensitivity masquerading as azithromycin hypersensitivity. Allergy Asthma Proc 30:95\u2013101","journal-title":"Allergy Asthma Proc"},{"key":"8919_CR127","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/ijd.15144","volume":"60","author":"AV Pej\u010di\u0107","year":"2021","unstructured":"Pej\u010di\u0107 AV (2021) Stevens-Johnson syndrome and toxic epidermal necrolysis associated with the use of macrolide antibiotics: a review of published cases. Int J Dermatol 60:12\u201324","journal-title":"Int J Dermatol"},{"key":"8919_CR128","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/bcpt.13011","volume":"123","author":"S-A Chen","year":"2018","unstructured":"Chen S-A, Zhang L-R, Yang F-P, Yang L-L, Yang Y, Chen Z-H et al (2018) HLA-A*02:07 allele associates with clarithromycin-induced cutaneous adverse drug reactions in Chinese patients. Basic Clin Pharmacol Toxicol 123:308\u2013313","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"8919_CR129","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1600-0536.2007.00999.x","volume":"56","author":"S Milkovi\u0107-Kraus","year":"2007","unstructured":"Milkovi\u0107-Kraus S, Macan J, Kanceljak-Macan B (2007) Occupational allergic contact dermatitis from azithromycin in pharmaceutical workers: a case series. Contact Dermatitis 56:99\u2013102","journal-title":"Contact Dermatitis"},{"key":"8919_CR130","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0924-8579(01)00397-1","volume":"18","author":"E Rubinstein","year":"2001","unstructured":"Rubinstein E (2001) Comparative safety of the different macrolides. Int J Antimicrob Agents 18:71\u201376","journal-title":"Int J Antimicrob Agents"},{"key":"8919_CR131","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jaip.2020.08.002","volume":"8","author":"AD Broyles","year":"2020","unstructured":"Broyles AD, Banerji A, Castells M (2020) Practical guidance for the evaluation and management of drug hypersensitivity: general concepts. J Allergy Clin Immunol Pract 8:S3-15","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8919_CR132","first-page":"3","volume":"104","author":"F Mori","year":"2010","unstructured":"Mori F, Barni S, Pucci N, Rossi E, Azzari C, de Martino M et al (2010) Sensitivity and specificity of skin tests in the diagnosis of clarithromycin allergy 104:3","journal-title":"Sensitivity and specificity of skin tests in the diagnosis of clarithromycin allergy"},{"key":"8919_CR133","first-page":"4","volume":"4","author":"O Cavkaytar","year":"2015","unstructured":"Cavkaytar O (2015) Testing for clarithromycin hypersensitivity: a diagnostic challenge in childhood 4:4","journal-title":"Testing for clarithromycin hypersensitivity: a diagnostic challenge in childhood"},{"key":"8919_CR134","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S0091-6749(95)70170-2","volume":"95","author":"C Pascual","year":"1995","unstructured":"Pascual C, Crespo JF, Quiralte J, Lopez C, Wheeler G, Martin-Esteban M (1995) In vitro detection of specific IgE antibodies to erythromycin. J Allergy Clin Immunol 95:668\u2013671","journal-title":"J Allergy Clin Immunol"},{"key":"8919_CR135","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1080\/003655402320208875","volume":"34","author":"E Nucera","year":"2002","unstructured":"Nucera E, Roncallo C, Masini L, Buonomo A, Pollastrini E, Schiavino D et al (2002) Successful tolerance induction to spiramycin in pregnancy. Scand J Infect Dis 34:550\u2013551","journal-title":"Scand J Infect Dis"},{"key":"8919_CR136","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.anai.2010.08.018","volume":"105","author":"N Swamy","year":"2010","unstructured":"Swamy N, Laurie SA, Ruiz-Huidobro E, Khan DA (2010) Successful clarithromycin desensitization in a multiple macrolide\u2013allergic patient. Ann Allergy Asthma Immunol 105:489\u2013490","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8919_CR137","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2125.2008.03192.x","volume":"66","author":"NE Holmes","year":"2008","unstructured":"Holmes NE, Hodgkinson M, Dendle C, Korman TM (2008) Report of oral clarithromycin desensitization. Br J Clin Pharmacol 66:323\u2013324","journal-title":"Br J Clin Pharmacol"},{"key":"8919_CR138","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/sj.bmt.1702223","volume":"25","author":"L Riley","year":"2000","unstructured":"Riley L, Mudd L, Baize T, Herzig R (2000) Cross-sensitivity reaction between tacrolimus and macrolide antibiotics. Bone Marrow Transplant 25:907\u2013908","journal-title":"Bone Marrow Transplant"},{"key":"8919_CR139","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1001\/archinte.1990.00390210145031","volume":"150","author":"RY Lin","year":"1990","unstructured":"Lin RY (1990) Desensitization in the management of vancomycin hypersensitivity. Arch Intern Med 150:2197\u20132198","journal-title":"Arch Intern Med"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08919-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-021-08919-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08919-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T09:04:45Z","timestamp":1700125485000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-021-08919-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,29]]},"references-count":139,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["8919"],"URL":"https:\/\/doi.org\/10.1007\/s12016-021-08919-5","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,29]]},"assertion":[{"value":"22 December 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Dr. Arroyo report grants from the National Institutes of Health, outside the submitted work. The remaining authors have nothing to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}